Trials / Completed
CompletedNCT04375943
Clinical and Echocardiographic Management of Patients With Heart Failure and Diabetes: SCODIAC Follow up Study
Clinical and Echocardiographic Management of Patients With Chronic Heart Failure and Type 2 Diabetes Mellitus: the SCODIAC Follow up Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 406 (actual)
- Sponsor
- Federico II University · Academic / Other
- Sex
- All
- Age
- 65 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The study has been carried out to determine diagnostic and therapeutic pathways in a group of HF diabetic patients and to verify whether the use of innovative antidiabetic therapies could modify echocardiographic parameters and influence cardiological therapy.
Detailed description
406 patients affected with heart failure and Type 2 Diabetes Mellitus, referred to Cardiologists and Diabetologists of pertaining healthcare districts in Campania, and followed for at least one year between 2018 and 2019, were enrolled in this retrospective study and divided in Group A, composed of 136 HF diabetic patients with preserved Ejection Fraction (HF-pEF) (\>45%) and Group B, formed of 270 HF diabetic patients with reduced EF (HF-rEF) (≤45%). All patients had performed periodic clinical evaluations and an echocardiographic exam every 12 months. Anthropometric parameters, HF etiology, co-morbidities, complications and ongoing therapies were collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antidiabetic | Verify whether the use of innovative antidiabetic therapies could modify echocardiographic parameters and influence cardiological therapy |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2019-04-01
- Completion
- 2019-09-01
- First posted
- 2020-05-06
- Last updated
- 2020-05-06
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04375943. Inclusion in this directory is not an endorsement.